Cargando…

Deciphering the Role of Insulin-Like Growth Factor-I Receptor in Trastuzumab Resistance

Resistance to the HER2-targeted antibody trastuzumab is a major clinical concern in the treatment of HER2-overexpressing metastatic breast cancer. Increased expression or signaling of the insulin-like growth factor-I receptor (IGF-IR) has been reported in a subset of cell lines and clinical samples...

Descripción completa

Detalles Bibliográficos
Autor principal: Nahta, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399380/
https://www.ncbi.nlm.nih.gov/pubmed/22830017
http://dx.doi.org/10.1155/2012/648965

Ejemplares similares